Issued Patents 2022
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11529350 | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof | Jeyaprakashnarayanan Seenisamy, Steven L. Warner, Clifford J. Whatcott, David J. Bearss | 2022-12-20 |
| 11530231 | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | Paul Flynn, Shuji Masumoto, Hiroaki Tanaka, Hirotaka Kurebayashi, Takahiko Hashizuka +1 more | 2022-12-20 |
| 11497756 | Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib | David J. Bearss, Clifford J. Whatcott, Steven L. Warner | 2022-11-15 |
| 11471456 | Formulations comprising heterocyclic protein kinase inhibitors | Steven L. Warner, Paul Flynn | 2022-10-18 |
| 11400091 | AXL kinase inhibitors and use of the same | Steven L. Warner, Paul Flynn, David J. Bearss, Jason Marc Foulks, Nozomi Tomimatsu +4 more | 2022-08-02 |
| 11279694 | Alvocidib prodrugs and their use as protein kinase inhibitors | Yusuke Sawayama, Wataru Hirose, Hitoshi Ban | 2022-03-22 |